In the present study, we demonstrated that the oligo-fucoidan greatly improves renal fibrosis under diabetic condition through inhibition of TGF-β1-activated pro-fibrogenic pathway via activation of Sirt-1, GLP-1R, and Nrf2/HO-1. The gene discussed is TGFB1; the disease is renal fibrosis.